Expert recommendations: the use of the fixed combination calcipotriol and betamethasone dipropionate gel for the topical treatment of psoriasis
Open Access
- 31 March 2014
- journal article
- review article
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 28 (s2) , 22-32
Abstract
Treatment non‐adherence is a general challenge and a complex problem. It is a key factor that impacts the ‘real‐life’ effectiveness of topical treatments for chronic disorders, such as psoriasis. Here, we provide our expert opinion on the real‐life effectiveness of topical psoriasis treatment, using the fixed combination gel (Daivobet® gel; calcipotriol plus betamethasone dipropionate) as a case study. The fixed combination gel is a first‐line topical treatment for mild‐to‐moderate psoriasis, developed to be the gold‐standard therapy for psoriasis patients. This fixed combination gel is an effective and well‐tolerated topical psoriasis treatment that the majority of our patients prefer to the ointment formulation. We assessed our real‐life experience and considered any gaps between daily practice and clinical trials data. We recommend a multifaceted approach to improve real‐life effectiveness and bridge the gap between investigational trials and treatment reality and propose the following recommendations: (1) educate primary healthcare providers on how to effectively manage topical psoriasis treatment and the patients who use the treatment; (2) educate the patient on why treatment needs to be maintained, even when symptoms improve; and (3) provide a supportive environment that will not allow the patient to feel abandoned. A patient‐centric approach may improve adherence, which will lead to patients receiving more effective treatment for psoriasis.Keywords
Funding Information
- LEO Pharma
This publication has 36 references indexed in Scilit:
- Assessment and management of psoriasis: summary of NICE guidanceBMJ, 2012
- Calcipotriol and betamethasone dipropionate in the treatment of mild-to-moderate psoriasis: a cost-effectiveness analysis of the ointment versus gel formulationClinicoEconomics and Outcomes Research, 2012
- Adherence to topical treatment in psoriasis: a systematic literature reviewJournal of the European Academy of Dermatology and Venereology, 2012
- German S3-guidelines on the treatment of psoriasis vulgaris (short version)Archives of Dermatological Research, 2012
- Combined treatment with low-dose cyclosporine and calcipotriol/betamethasone dipropionate ointment for moderate-to-severe plaque psoriasis: a randomized controlled open-label studyJournal of Dermatological Treatment, 2011
- Maximizing patient adherence for optimal outcomes in psoriasisJournal of the European Academy of Dermatology and Venereology, 2011
- A phase IIIb, multicentre, randomized, double-blind, vehicle-controlled study of the efficacy and safety of adalimumab with and without calcipotriol/betamethasone topical treatment in patients with moderate to severe psoriasis: the BELIEVE studyBritish Journal of Dermatology, 2010
- Guidelines of care for the management of psoriasis and psoriatic arthritisJournal of the American Academy of Dermatology, 2009
- Quality of life in patients with psoriasisHealth and Quality of Life Outcomes, 2006
- Adherence to MedicationNew England Journal of Medicine, 2005